Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines

There are limited treatment options for patients with advanced vulvar cancer. However, several immune checkpoint inhibitors (ICIs) are FDA-approved or NCCN-Compendia–listed for qualified patients with advanced disease. In this case report, we present a patient with metastatic vulvar squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Praiss, Aaron, Navitski, Anastasia, Cohen, Seth, Tessier-Cloutier, Basile, Broach, Vance, O'Cearbhaill, Roisin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048086/
https://www.ncbi.nlm.nih.gov/pubmed/35496740
http://dx.doi.org/10.1016/j.gore.2022.100982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048086/
https://www.ncbi.nlm.nih.gov/pubmed/35496740
http://dx.doi.org/10.1016/j.gore.2022.100982

Ejemplares similares